These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 27085046)
1. Readily restoring freeze-dried probilosomes as potential nanocarriers for enhancing oral delivery of cyclosporine A. Guan P; Lu Y; Qi J; Wu W Colloids Surf B Biointerfaces; 2016 Aug; 144():143-151. PubMed ID: 27085046 [TBL] [Abstract][Full Text] [Related]
2. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Guan P; Lu Y; Qi J; Niu M; Lian R; Hu F; Wu W Int J Nanomedicine; 2011; 6():965-74. PubMed ID: 21720508 [TBL] [Abstract][Full Text] [Related]
3. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats. Yang ZQ; Xu J; Pan P; Zhang XN Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems. Wang K; Qi J; Weng T; Tian Z; Lu Y; Hu K; Yin Z; Wu W Int J Nanomedicine; 2014; 9():4991-9. PubMed ID: 25378925 [TBL] [Abstract][Full Text] [Related]
5. Solidification of liposomes by freeze-drying: the importance of incorporating gelatin as interior support on enhanced physical stability. Guan P; Lu Y; Qi J; Niu M; Lian R; Wu W Int J Pharm; 2015 Jan; 478(2):655-64. PubMed ID: 25510601 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization. Khalil RM; Abdelbary A; Kocova El-Arini S; Basha M; El-Hashemy HA J Liposome Res; 2019 Jun; 29(2):171-182. PubMed ID: 30221568 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles. Lai J; Lu Y; Yin Z; Hu F; Wu W Int J Nanomedicine; 2010 Feb; 5():13-23. PubMed ID: 20161984 [TBL] [Abstract][Full Text] [Related]
8. Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate. Elnaggar YSR; Omran S; Hazzah HA; Abdallah OY Int J Pharm; 2019 Jun; 564():410-425. PubMed ID: 31029657 [TBL] [Abstract][Full Text] [Related]
10. Nanosized Liposomes Containing Bile Salt: A Vesicular Nanocarrier for Enhancing Oral Bioavailability of BCS Class III Drug. Arafat M; Kirchhoefer C; Mikov M; Sarfraz M; Löbenberg R J Pharm Pharm Sci; 2017; 20(0):305-318. PubMed ID: 28885915 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-functionalized bilosomes for targeted delivery of tripterine to inflamed area with enhancive therapy on arthritis. Yang H; Liu Z; Song Y; Hu C Drug Deliv; 2019 Dec; 26(1):820-830. PubMed ID: 31389248 [TBL] [Abstract][Full Text] [Related]
12. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge. Arzani G; Haeri A; Daeihamed M; Bakhtiari-Kaboutaraki H; Dadashzadeh S Int J Nanomedicine; 2015; 10():4797-813. PubMed ID: 26251598 [TBL] [Abstract][Full Text] [Related]
13. Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats. Ahad A; Raish M; Ahmad A; Al-Jenoobi FI; Al-Mohizea AM Eur J Pharm Sci; 2018 Jan; 111():409-417. PubMed ID: 29030177 [TBL] [Abstract][Full Text] [Related]
14. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration. Wang XQ; Dai JD; Chen Z; Zhang T; Xia GM; Nagai T; Zhang Q J Control Release; 2004 Jul; 97(3):421-9. PubMed ID: 15212874 [TBL] [Abstract][Full Text] [Related]
15. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. Dai J; Nagai T; Wang X; Zhang T; Meng M; Zhang Q Int J Pharm; 2004 Aug; 280(1-2):229-40. PubMed ID: 15265562 [TBL] [Abstract][Full Text] [Related]
16. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Al-Mahallawi AM; Abdelbary AA; Aburahma MH Int J Pharm; 2015 May; 485(1-2):329-40. PubMed ID: 25796122 [TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model. Melero A; Draheim C; Hansen S; Giner E; Carreras JJ; Talens-Visconti R; Garrigues TM; Peris JE; Recio MC; Giner R; Lehr CM Eur J Pharm Biopharm; 2017 Oct; 119():361-371. PubMed ID: 28709903 [TBL] [Abstract][Full Text] [Related]
18. Molecular docking and statistical optimization of taurocholate-stabilized galactose anchored bilosomes for the enhancement of sofosbuvir absorption and hepatic relative targeting efficiency. Joseph Naguib M; Moustafa Kamel A; Thabet Negmeldin A; Elshafeey AH; Elsayed I Drug Deliv; 2020 Dec; 27(1):996-1009. PubMed ID: 32611266 [TBL] [Abstract][Full Text] [Related]
19. Bile salt liposomes for enhanced lymphatic transport and oral bioavailability of paclitaxel. Zhang B; Xue A; Zhang C; Yu J; Chen W; Sun D Pharmazie; 2016 Jun; 71(6):320-6. PubMed ID: 27455550 [TBL] [Abstract][Full Text] [Related]
20. [Preparation of cyclosporine A pH sensitive nanoparticles and oral pharmacokinetics in rats]. Dai JD; Wang XQ; Zhang T; Meng M; Zhang X; Lü WL; Zhang Q Yao Xue Xue Bao; 2004 Dec; 39(12):1023-7. PubMed ID: 15813034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]